This site is intended for health professionals only
Thursday 15 November 2018
Share |

Topic: Diagnostics

February 15, 2018
With the current situation, diagnosis of atrial fibrillation is a lengthy and expensive process, sometimes taking years

KardiaMobile, a revolutionary and potentially life-saving heart monitor, is being distributed to the NHS in England.

January 9, 2018
Partnership will apply advanced analytics to in vivo data from GE’s medical imaging and monitoring equipment with in vitro data from Roche’s biomarker, tissue pathology, genomics and sequencing portfolio

Roche has announced that it has entered into a strategic, long-term partnership with GE Healthcare in order to jointly develop and co-market digital clinical decision support solutions.

September 14, 2017
University Hospitals Birmingham NHS Foundation Trust and Roche Diagnostics introduce pioneering approach to lung cancer diagnosis

A simple test which can detect gene mutations in tumour DNA from blood samples is giving new choices to lung cancer patients with faster diagnosis and improved access to life changing drugs.

July 24, 2017
The time for diagnoses based on incomplete datasets is at an end; we must connect the ‘ologies’ with all of medicine, writes Brendan Devlin, a practising radiologist and Senior Clinical Advisor to Sectra

There are some who might feel uneasy about integrating the way we work in diagnostics. Disciplines, sometimes dating back to the beginnings of modern medicine, have had their own way of working, their own culture, philosophy and an established place in patient care.

March 21, 2016
BD Vacutainer® Barricor™Tube designed to enhance sample quality, improve laboratory efficiency and speed laboratory turnaround time

BD (Becton, Dickinson and Company), a leading global medical technology company, has announced that it has obtained the CE mark in Europe for a next-generation blood separation technology that is designed to enhance sample quality, improve laboratory efficiency and reduce laboratory turnaround time.

BD Vacutainer® Barricor™ tube is a single-use, plastic evacuated tube used to collect, separate, transport and process venous blood specimens to obtain high-quality plasma for in vitro diagnostic use.

July 1, 2015
Planmed introduces a new mammography unit, which utilises advanced Digital Breast Tomosynthesis (DBT) technology. DBT enables enhanced diagnostics, especially for patients with denser breast tissue

Digital Breast Tomosynthesis resolves the challenge of overlapping tissue structures by producing a 3D volume of the breast. As a whole, Planmed Clarity 3D enables sharp reconstructions with a higher visibility of microcalcifications and delicate tissue structures through its patented Continuous Sync-and-Shoot™ method. This new approach to tomosynthesis imaging eliminates motion blur and artefact intrusion, ensuring that small calcifications and blood vessels can be seen with clarity.

June 22, 2015
Previously pathologists would have to assess physical slides under a microscope and post them by mail for a second opinion. This could result in delays and risk slides being lost or damaged.

Previously pathologists would have to assess physical slides under a microscope and post them by mail for a second opinion. This could result in delays and risk slides being lost or damaged.
 

June 11, 2015
The Global Fund, an organisation dedicated to overcoming AIDS, tuberculosis and malaria, selected Abbott as one of seven diagnostic companies to help provide affordable, high-quality infectious disease testing to low and middle income countries. Under the agreement, Abbott will offer its HIV viral load tests – which monitor the amount of HIV in a person's blood – at reduced prices to help provide access to quality care in high-burden countries affected by this virus.

The Global Fund, an organisation dedicated to overcoming AIDS, tuberculosis and malaria, selected Abbott as one of seven diagnostic companies to help provide affordable, high-quality infectious disease testing to low and middle income countries. Under the agreement, Abbott will offer its HIV viral load tests – which monitor the amount of HIV in a person's blood – at reduced prices to help provide access to quality care in high-burden countries affected by this virus.

June 11, 2015
Beckman Coulter Diagnostics has obtained CE marking for its DxN VERIS HCV Assay*, a real-time PCR assay for the rapid and reliable quantitative determination of Hepatitis C Virus (HCV) RNA in human plasma, and DxN VERIS HIV-1 Assay*, a real-time PCR assay for the rapid and reliable quantitative measurement of Human Immunodeficiency Virus type 1 (HIV-1) in human plasma. The two assays are the latest additions to the growing menu of CE-marked assays for use on the DxN VERIS Molecular Diagnostics System.*

Beckman Coulter Diagnostics has obtained CE marking for its DxN VERIS HCV Assay*, a real-time PCR assay for the rapid and reliable quantitative determination of Hepatitis C Virus (HCV) RNA in human plasma, and DxN VERIS HIV-1 Assay*, a real-time PCR assay for the rapid and reliable quantitative measurement of Human Immunodeficiency Virus type 1 (HIV-1) in human plasma. The two assays are the latest additions to the growing menu of CE-marked assays for use on the DxN VERIS Molecular Diagnostics System.*

May 11, 2015
This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks. Tuberculosis (TB) disease rates in some parts of London are as high as in Sub-Saharan Africa, and drug-resistant strains are becoming increasingly common. These require specific treatments, and if doctors know that a bug is resistant they can start therapy earlier, often leading to better outcomes.

This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks. Tuberculosis (TB) disease rates in some parts of London are as high as in Sub-Saharan Africa, and drug-resistant strains are becoming increasingly common. These require specific treatments, and if doctors know that a bug is resistant they can start therapy earlier, often leading to better outcomes.

April 23, 2015
EKF Diagnostics, the global diagnostics company, announces that it has launched its next generation Hemo Control point-of-care (POC) diagnostics analyser, providing laboratory accurate haemoglobin and haematocrit results in one simple test. Uniquely the new haemoglobin POC analyser enables full upgrade with Data Management functionality as required, giving the user complete flexibility over their future connectivity options via its bi-directional interface.

EKF Diagnostics, the global diagnostics company, announces that it has launched its next generation Hemo Control point-of-care (POC) diagnostics analyser, providing laboratory accurate haemoglobin and haematocrit results in one simple test. Uniquely the new haemoglobin POC analyser enables full upgrade with Data Management functionality as required, giving the user complete flexibility over their future connectivity options via its bi-directional interface.
 

April 21, 2015
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organisation that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – has warned that Britain and Europe collectively could face more than a million deaths in an impending "Antibiotic Armageddon” unless more is done to develop new cures, rapid diagnostics and preventative measures to combat the spread of drug resistant diseases.

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organisation that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – has warned that Britain and Europe collectively could face more than a million deaths in an impending "Antibiotic Armageddon” unless more is done to develop new cures, rapid diagnostics and preventative measures to combat the spread of drug resistant diseases.

November 28, 2014
The MAGNETOM® Aera MR and SOMATOM® Definition AS CT systems are providing patients with easily accessible diagnostic treatment, as rapidly as possible. The newly built suite is specifically designed to optimise patient comfort and radiographer efficiency.

The MAGNETOM® Aera MR and SOMATOM® Definition AS CT systems are providing patients with easily accessible diagnostic treatment, as rapidly as possible. The newly built suite is specifically designed to optimise patient comfort and radiographer efficiency.
 

November 12, 2014
New Oncology announced that it has entered into collaboration with the National Cancer Centre Singapore (NCCS). Under this agreement, New Oncology will apply its proprietary diagnostic platform ‘NEO’ that enables physicians to select optimal targeted therapies for their patients.

New Oncology announced that it has entered into collaboration with the National Cancer Centre Singapore (NCCS). Under this agreement, New Oncology will apply its proprietary diagnostic platform ‘NEO’ that enables physicians to select optimal targeted therapies for their patients.

 

October 20, 2014
GE Healthcare shares a suite of advances in imaging quantitation that may help clinicians diagnose disease earlier, deliver more personalised treatment and speed up care at the 27th annual meeting of the European Association of Nuclear Medicine (EANM), 18-22 October, in Gothenburg.

GE Healthcare shares a suite of advances in imaging quantitation that may help clinicians diagnose disease earlier, deliver more personalised treatment and speed up care at the 27th annual meeting of the European Association of Nuclear Medicine (EANM), 18-22 October, in Gothenburg.
 

October 9, 2014
An electronic device giving visual and audible feedback on how people with severe lung diseases breathe in and out, motivating them to perform vital lung clearing exercises, is one of four flagship innovations from Sheffield Teaching Hospitals NHS Foundation Trust being showcased at a major regional awards ceremony.

An electronic device giving visual and audible feedback on how people with severe lung diseases breathe in and out, motivating them to perform vital lung clearing exercises, is one of four flagship innovations from Sheffield Teaching Hospitals NHS Foundation Trust being showcased at a major regional awards ceremony.
 

April 21, 2008
A bacteria testing product is able to detect 50 dangerous bugs simultaneously, according to its manufacturers

A bacteria testing product developed by a Finnish biotechnology company has set a world record by being able to detect 50 dangerous bugs simultaneously, according to its manufacturers.

Mobidiag claims this development is an important milestone in the battle against infectious diseases, especially life-threatening sepsis.

April 2, 2008
The Molecular Pathology at the Dept of Pathology, Uppsala University Hospital, is evaluating the new PyroMark Q24TM to implement the Pyrosequencing® technology in cancer diagnostics

The Molecular Pathology unit at the Department of Pathology, Uppsala University Hospital, is evaluating the new PyroMark Q24TM to implement the Pyrosequencing® technology in cancer diagnostics.

Several novel drugs against the growth hormone receptor EGFR have been recently approved for the treatment of advanced colorectal and lung cancer. The efficacy of all of these drugs is strongly connected to the mutation status of the gene k-ras.

March 26, 2008
A report has suggested that there will be an uptake in the purchase of MS instruments for clinical diagnostics, but costs are likely to remain high

A report by a consulting company has suggested that there will be an uptake in the purchase of mass spectrometry (MS) instruments for clinical diagnostics in the next few years, but costs for hospitals and laboratories are likely to remain high.

The study, called “Opportunities for the European Mass Spectrometry Market in Clinical Applications”, produced by Frost & Sullivan, found that the European market earned revenues of $562m in 2007 with $1,078.8m expected for 2014.